Correction to: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features
Crossref DOI link: https://doi.org/10.1007/s40261-019-00852-y
Published Online: 2019-09-12
Published Print: 2019-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lyseng-Williamson, Katherine A. http://orcid.org/0000-0002-5104-1158
Text and Data Mining valid from 2019-09-12
Version of Record valid from 2019-09-12
Article History
First Online: 12 September 2019